Corden Pharma Bergamo

Managing Director:

Laura Coppi

Corden Pharma Bergamo S.p.A.
Via Bergamo 121
24047 Treviglio
Phone:+39 0363 31401
Fax:+39 0363 45985

Get Driving Directions:

Get Directions

Core Capabilities

  • cGMP custom synthesis from lab to multi-tonne scale
  • Multi-step API process development, manufacturing and analytical development
  • Industrialization from feasibility to commercial scale
  • Regulatory filing in the US, EU and Japan

Compliance Approvals

  • FDA approved (DMF type 1 number 3802) and regularly inspected by the Italian Health Ministry and by customers, in addition to FDA inspections
  • CordenPharma Bergamo quality system is certified by Certiquality according to ISO 9001:2008 under Certificate No 693

CordenPharma Bergamo Ethical Code

Facility Legacy

CordenPharma Bergamo is a cGMP manufacturer of advanced pharmaceutical intermediates and APIs specializing in the design of synthetic routes and development processes for new products from laboratory to commercial scale, with equipment and chemical technologies that are particularly suitable for multi-step synthesis.

CordenPharma Bergamo brings over 40 years of experience and expertise in pharmaceutical chemistry, technology, project management and registration processes to CordenPharma’s full-service CMO platform.


  • 1962 Started by a private owner
  • 1979 First FDA Inspection
  • 1989 Facility purchased by Tessenderlo Group
  • 2012 Farchemia acquired by ICIG
  • 2016 Name changed to Corden Pharma Bergamo S.p.A.